Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
The Journal of Infectious Diseases|April 25, 2001
Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapyG Tambussi, S Ghezzi, S Nozza, et al.The Journal of Experimental Medicine|August 4, 1997
Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 alleleL Furci, G Scarlatti, S Burastero, et al.The Journal of Clinical Investigation|March 23, 2000
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNAG P Rizzardi, R J De Boer, S Hoover, et al.Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaG Pantaleo, J F Demarest, T Schacker, et al.AIDS (London, England)|September 21, 2000
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapyP A Bart, G P Rizzardi, G Tambussi, et al.Journal of Virus Eradication|June 18, 2021
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure ConsortiumC Rokx, H A B Prins, L Vandekerckhove, et al.The New England Journal of Medicine|October 16, 2009
Interleukin-2 therapy in patients with HIV infection, , D Abrams, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2012
Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter studyY Lévy, I Sereti, G Tambussi, et al.Reviews on Recent Clinical Trials|December 24, 2009
Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidateS Bellino, V Francavilla, O Longo, et al.HIV Medicine|June 25, 2020
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohortL Taramasso, M Fabbiani, S Nozza, et al.Pageof 11